CRISPRMED24 Testimonial - Pietro De Angeli PhD
By: WeDoCRISPR - Nov. 24, 2024
Pietro De Angeli PhD is a Project Lead Scientist in Professor Bernd Wissinger’s team at the Institute for Ophthalmic Research, Tübingen University Hospital, Germany. Here, he is involved in pre-clinical gene-editing research for inherited retinal disorders. Hear what he has to say anout CRISPRMED24!
Tags
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
Type 1 Primary Hyperoxaluria, PH1, (NCT06892301)
Sponsors:
Guangzhou Women and Children's Medical Center
Sponsors:
Guangzhou Women and Children's Medical Center
IND Enabling
Phase I
Phase II
Phase III
End-Stage Renal Disease, (NCT07053462)
Sponsors:
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Sponsors:
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
IND Enabling
Phase I
Phase II
Phase III